Single Use Support announces the appointment of Davy De Wilde as the company’s new Chief Commercial Officer (CCO), effective February 2nd 2026. He will lead the global commercial organization of the biopharma process solution provider and to suppo...
The Chinese biopharm company 3S BIO has more than 30 listed products and currently 32 products under development. It covers treatments in oncology, autoimmune diseases, nephrology, metabolism, dermatology and other related areas of treatment. F...
